Microbiota and microRNAs in lung diseases: mutual influence and role insights
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):13000-13008. doi: 10.26355/eurrev_202012_24205. PMID: 33378051
We speculated a model of lung immune regulation driven by the axis microbiota-microRNAs, involving asthma, acute injury, cancer and COPD. Based on this axis, we propose a novel approach based on the modification of microRNAs expression centered not exclusively on antagomiR …